WilliamDouglasThomasIIDO

PubMed

• Pre-exposure Prophylaxis With OspA-Specific Human Monoclonal Antibodies Protects Mice Against Tick Transmission of Lyme Disease Spirochetes.
  Wang Y, Kern A, Boatright NK, Schiller ZA, Sadowski A, Ejemel M, Souders CA, Reimann KA, Hu L, Thomas WD, Klempner MS> ;J. Infect. Dis.. 2016-07-15
• Identification of a human monoclonal antibody to replace equine diphtheria antitoxin for treatment of diphtheria intoxication.
  Sevigny LM, Booth BJ, Rowley KJ, Leav BA, Cheslock PS, Garrity KA, Sloan SE, Thomas W, Babcock GJ, Wang Y> ;Infect. Immun.. 2013-11-01
• Age-specific prevalence of Epstein-Barr virus infection among individuals aged 6-19 years in the United States and factors affecting its acquisition.
  Balfour HH, Sifakis F, Sliman JA, Knight JA, Schmeling DO, Thomas W> ;J. Infect. Dis.. 2013-10-15
• Behavioral, virologic, and immunologic factors associated with acquisition and severity of primary Epstein-Barr virus infection in university students.
  Balfour HH, Odumade OA, Schmeling DO, Mullan BD, Ed JA, Knight JA, Vezina HE, Thomas W, Hogquist KA> ;J. Infect. Dis.. 2013-01-01
• Corruption of phage display libraries by target-unrelated clones: diagnosis and countermeasures.
  Thomas, W.D., Golomb, M., Smith, G.P.> ;Anal Biochem. 2010 Dec 15
• The case for trypsin release of affinity-selected phages.
  Thomas WD, Smith GP> ;BioTechniques. 2010-09-01
• Treatment with monoclonal antibodies against Clostridium difficile toxins.
  Lowy, I., Molrine, D.C., Leav, B.A., Blair, B.M., Baxter, R., Gerding, D.N., Nichol, G., Thomas, W.D., Leney, M., Sloan, S., Hay, C.A., Ambrosino, D.M.> ;N Engl J Med. 2010 Jan 21
• Identification and characterization of broadly neutralizing human monoclonal antibodies directed against the E2 envelope glycoprotein of hepatitis C virus.
  Broering, T.J., Garrity, K.A., Boatright, N.K., Sloan, S.E., Sandor, F., Thomas, W.D., Szabo, G., Finberg, R.W., Ambrosino, D.M., Babcock, G.J.> ;J Virol. 2009-12-01
• Human monoclonal antibodies directed against toxins A and B prevent Clostridium difficile-induced mortality in hamsters.
  Babcock, G.J., Broering, T.J., Hernandez, H.J., Mandell, R.B., Donahue, K., Boatright, N., Stack, A.M., Lowy, I., Graziano, R., Molrine, D., Ambrosino, D.M., Thomas, W.D.> ;Infect Immun. 2006 Nov
• Therapy with a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody reduces disease severity and viral burden in golden Syri...
  Roberts, A., Thomas, W.D., Guarner, J., Lamirande, E.W., Babcock, G.J., Greenough, T.C., Vogel, L., Hayes, N., Sullivan, J.L., Zaki, S., Subbarao, K., Ambrosino, D.M.> ;J Infect Dis. 2006 Mar 1
• Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunopro...
  > ;J Infect Dis. 2005 Feb 15
• CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus.
  Jeffers, S.A., Tusell, S.M., Gillim-Ross, L., Hemmila, E.M., Achenbach, J.E., Babcock, G.J., Thomas, W.D., Thackray, L.B., Young, M.D., Mason, R.J., Ambrosino, D.M., W...> ;Proc Natl Acad Sci U S A. 2004 Nov 2
• Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor.
  Babcock, G.J., Esshaki, D.J., Thomas, W.D., Ambrosino, D.M.> ;J Virol. 2004 May
• Surface plasmon resonance imaging studies of protein-carbohydrate interactions.
  Smith, E.A., Thomas, W.D., Kiessling, L.L., Corn, R.M.> ;J Am Chem Soc. 2003 May 21
• Parallel synthesis of glycomimetic libraries: targeting a C-type lectin.
  Schuster, M.C., Mann, D.A., Buchholz, T.J., Johnson, K.M., Thomas, W.D., Kiessling, L.L.> ;Org Lett. 2003 May 1
• Join now to see all